December 12, 2025 · Form 4 insider transaction
Roivant Sciences Ltd. bought 16,666,666 shares of Immunovant, Inc. at $21.00 per share, a transaction worth $350.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.